SEC Form 4 · accession 0001140361-15-011730
Great Basin Scientific, Inc. · GBSN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Spafford
Director
Period of report
Mar 11, 2015
Accepted (ET)
Mar 13, 2015 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001512138
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series E Convertible Preferred StockF3,F1,F2 | — | Mar 11, 2015 | P | 7,450 | A | — | — | Common Stock | 29,800 | 7,450 | I |
| Series E Convertible Preferred StockF4,F1,F2 | — | Mar 12, 2015 | P | 10,000 | A | — | — | Common Stock | 40,000 | 17,450 | I |
| Series E Convertible Preferred StockF5,F1,F2 | — | Mar 13, 2015 | P | 3,300 | A | — | — | Common Stock | 13,200 | 20,750 | I |
| Series C Common Stock WarrantsF3,F2 | $2.55 | Mar 11, 2015 | P | 59,600 | A | — | Feb 25, 2020 | Common Stock | 59,600 | 59,600 | I |
| Series C Common Stock WarrantsF4,F2 | $2.55 | Mar 12, 2015 | P | 80,000 | A | — | Feb 25, 2020 | Common Stock | 80,000 | 139,600 | I |
| Series C Common Stock WarrantsF5,F2 | $2.55 | Mar 13, 2015 | P | 26,400 | A | — | Feb 25, 2020 | Common Stock | 26,400 | 166,000 | I |
Explanation of responses
- F1Each share of Series E Convertible Preferred Stock is convertible into four shares of common stock and has no expiration date.
- F2The Series E Convertible Preferred Stock is convertible, and the Series C Warrants are exercisable, upon the earlier of August 25, 2015 or the "Early Separation" of the Units. This Early Separation occurs if at any time after March 27, 2015 the closing price of our common stock is greater than $4.00 per share for 20 consecutive trading days, which we refer to as the "Separation Trigger Date". In the event of Early Separation, the Series E Convertible Preferred stock will become convertible, and the Series C Warrants will become exercisable, 15 days after the Separation Trigger Date.
- F3The reported securities are included within 7,450 Units purchased by the reporting person for $9.2119 per Unit. Each Unit consists of one share of Series E Convertible Preferred Stock, which is convertible into four shares of common stock, and eight Series C Warrants.
- F4The reported securities are included within 10,000 Units purchased by the reporting person for $9.8564 per Unit. Each Unit consists of one share of Series E Convertible Preferred Stock, which is convertible into four shares of common stock, and eight Series C Warrants.
- F5The reported securities are included within 3,300 Units purchased by the reporting person for $10.20 per Unit. Each Unit consists of one share of Series E Convertible Preferred Stock, which is convertible into four shares of common stock, and eight Series C Warrants.